PL199908A1 - Sposob wytwarzania nowych zwiazkow blokujacych receptory h dol 2 histaminy - Google Patents
Sposob wytwarzania nowych zwiazkow blokujacych receptory h dol 2 histaminyInfo
- Publication number
- PL199908A1 PL199908A1 PL19990877A PL19990877A PL199908A1 PL 199908 A1 PL199908 A1 PL 199908A1 PL 19990877 A PL19990877 A PL 19990877A PL 19990877 A PL19990877 A PL 19990877A PL 199908 A1 PL199908 A1 PL 199908A1
- Authority
- PL
- Poland
- Prior art keywords
- histamines
- dol
- making new
- blocking compounds
- new blocking
- Prior art date
Links
- 230000000903 blocking effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3139176 | 1976-07-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL199908A1 true PL199908A1 (pl) | 1978-11-20 |
| PL107847B1 PL107847B1 (pl) | 1980-03-31 |
Family
ID=10322405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1977199908A PL107847B1 (pl) | 1976-07-28 | 1977-07-28 | Method of producing new alpha-omega diguanidinoalksposob wytwarzania nowych alfa,omega dwuguanidynoalkanow anes |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5315370A (pl) |
| AU (1) | AU2734677A (pl) |
| BE (1) | BE857218A (pl) |
| CA (1) | CA1070315A (pl) |
| DE (1) | DE2733953A1 (pl) |
| DK (1) | DK331877A (pl) |
| ES (1) | ES461100A2 (pl) |
| FI (1) | FI772293A7 (pl) |
| FR (1) | FR2359840A1 (pl) |
| IL (1) | IL52544A0 (pl) |
| LU (1) | LU77845A1 (pl) |
| NL (1) | NL7708375A (pl) |
| NO (1) | NO772668L (pl) |
| PL (1) | PL107847B1 (pl) |
| ZA (1) | ZA774552B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| FR2446829A1 (fr) * | 1978-11-16 | 1980-08-14 | Glaxo Group Ltd | Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant |
| JPS57102852A (en) * | 1980-12-19 | 1982-06-26 | Shionogi & Co Ltd | Dicarboxylic acid diamide |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
-
1977
- 1977-07-18 IL IL52544A patent/IL52544A0/xx unknown
- 1977-07-22 DK DK331877A patent/DK331877A/da not_active Application Discontinuation
- 1977-07-26 LU LU77845A patent/LU77845A1/xx unknown
- 1977-07-26 AU AU27346/77A patent/AU2734677A/en active Pending
- 1977-07-27 NO NO772668A patent/NO772668L/no unknown
- 1977-07-27 DE DE19772733953 patent/DE2733953A1/de not_active Withdrawn
- 1977-07-27 FR FR7723079A patent/FR2359840A1/fr not_active Withdrawn
- 1977-07-27 BE BE179687A patent/BE857218A/xx unknown
- 1977-07-27 CA CA283,619A patent/CA1070315A/en not_active Expired
- 1977-07-27 ZA ZA00774552A patent/ZA774552B/xx unknown
- 1977-07-27 FI FI772293A patent/FI772293A7/fi not_active Application Discontinuation
- 1977-07-28 NL NL7708375A patent/NL7708375A/xx not_active Application Discontinuation
- 1977-07-28 JP JP9132477A patent/JPS5315370A/ja active Pending
- 1977-07-28 ES ES461100A patent/ES461100A2/es not_active Expired
- 1977-07-28 PL PL1977199908A patent/PL107847B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2734677A (en) | 1979-02-01 |
| ES461100A2 (es) | 1978-12-01 |
| JPS5315370A (en) | 1978-02-13 |
| FI772293A7 (pl) | 1978-01-29 |
| NL7708375A (nl) | 1978-01-31 |
| NO772668L (no) | 1978-01-31 |
| ZA774552B (en) | 1978-06-28 |
| FR2359840A1 (fr) | 1978-02-24 |
| DK331877A (da) | 1978-01-29 |
| BE857218A (fr) | 1978-01-27 |
| PL107847B1 (pl) | 1980-03-31 |
| CA1070315A (en) | 1980-01-22 |
| LU77845A1 (pl) | 1977-10-25 |
| DE2733953A1 (de) | 1978-02-02 |
| IL52544A0 (en) | 1977-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL201586A1 (pl) | Sposob wytwarzania nowych zwiazkow spiro-hydantionowych | |
| PL196505A1 (pl) | Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych | |
| PL211753A1 (pl) | Sposob wytwarzania nowych 1,1-dwuoksydo-4-hydroksy-2h-1,2-benzotiazyno-3-karboksyamidow | |
| PL201286A1 (pl) | Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow | |
| PL200289A1 (pl) | Sposob wytwarzania zwiazkow 3-chlorocefemowych | |
| PL199533A1 (pl) | Sposob wytwarzania fioletowego ticl dol 3 | |
| PL201837A1 (pl) | Sposob wytwarzania zwiazkow cynoorganicznych | |
| PL200251A1 (pl) | Sposob wytwarzania nowych podstawionych 2-fenyloaminoimidazolin-/2/ | |
| PL200583A1 (pl) | Sposob wytwarzania nowych pochodnych benzopiranu | |
| PL200534A1 (pl) | Sposob wytwarzania nowych oksadeztiacefalosporyn | |
| PL199909A1 (pl) | Sposob wytwarzania nowych zwiazkow blokujacych receptory h dol 2 histaminy | |
| PL200605A1 (pl) | Sposob wytwarzania nowych pochodnych metioninoenkefaliny | |
| PL204041A1 (pl) | Sposob wytwarzania nowych pochodnych 4"-aminooleandomycyny | |
| PL199908A1 (pl) | Sposob wytwarzania nowych zwiazkow blokujacych receptory h dol 2 histaminy | |
| PL202660A1 (pl) | Sposob wytwarzania nowych pochodnych spirooksazolidynodionu | |
| PL201133A1 (pl) | Sposob wytwarzania nowych pirydobenzodwuazepinonow | |
| PL201839A1 (pl) | Sposob wytwarzania zwiazkow cynoorganicznych | |
| PL201161A1 (pl) | Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu | |
| PL203486A1 (pl) | Sposob wytwarzania nowych pochodnych 6,7-dwumetoksy-1,2,3,4-czterowodoro-1-izochinolino-acetamidu | |
| PL196061A1 (pl) | Sposob wytwarzania nowych pochodnych indolizyny | |
| PL197311A1 (pl) | Sposob wytwarzania nowych zwiazkow ketotia | |
| PL201883A1 (pl) | Sposob wytwarzania nowych pochodnych trans-5a-arylo-dziesieciowodorobenzazepiny | |
| PL206687A1 (pl) | Sposob wytwarzania nowych pochodnych 4"-dezoksy-4"-sulfonylooleandomycyny | |
| PL196543A1 (pl) | Sposob wytwarzania nowych pochodnych azyrydyny | |
| PL200287A1 (pl) | Sposob wytwarzania 2,5-dwuhydroksybenzenosulfonianow |